BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:VH4770359 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of VH4770359\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07525544-980@assetmemo.bio
DTSTAMP:20261121T005642Z
DTSTART;VALUE=DATE:20270505
DTEND;VALUE=DATE:20270506
SUMMARY:VH4770359: Phase 1 readout est. (NCT07525544)
DESCRIPTION:VH4770359\, phase 1\, HIV.\nStudy: A Study to Investigate the S
 afety and PK of VH4770359 in Healthy Participants\nEstimated primary compl
 etion: 5 May 2027. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/vh
 4770359#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07525544
URL:https://assetmemo.bio/drug/vh4770359#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
